Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration-Reference-Cited by-同舟云学术

Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration

Published:1998-04 Issue:17 Volume:273 Page:10095-10098
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

White John R.,Lee Judithann M.,Young Peter R.,Hertzberg Robert P.,Jurewicz Anthony J.,Chaikin Margery A.,Widdowson Katherine,Foley James J.,Martin Lenox D.,Griswold Don E.,Sarau Henry M.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference41 articles.

1. Some aspects of IL-8 pathophysiology III: chemokine interaction with endothelial cells

2. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils.

3. Structure and Functional Expression of a Human Interleukin-8 Receptor

4. Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor

5. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1;ChemMedChem;2024-07-24

2. Development of a Fluorescent Ligand for the Intracellular Allosteric Binding Site of the Neurotensin Receptor 1;ACS Pharmacology & Translational Science;2024-04-18

3. Apical extrusion prevents apoptosis from activating an acute inflammatory program in epithelia;Developmental Cell;2023-11

4. IL-8 Triggers Neutrophil Extracellular Trap Formation Through an Nicotinamide Adenine Dinucleotide Phosphate Oxidase- and Mitogen-Activated Protein Kinase Pathway-Dependent Mechanism in Uveitis;Investigative Opthalmology & Visual Science;2023-10-12

5. Role of IL8 in myeloid malignancies;Leukemia & Lymphoma;2023-07-19